Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Treasury Shares (2016 - 2025)

Firefly Neuroscience has reported Treasury Shares over the past 14 years, most recently at $965211.0 for Q2 2024.

  • Quarterly results put Treasury Shares at $965211.0 for Q2 2024, changed 0.0% from a year ago — trailing twelve months through Jun 2024 was $965211.0 (changed 0.0% YoY), and the annual figure for FY2023 was $965211.0, changed 0.0%.
  • Treasury Shares for Q4 2025 was $172416.0 at Firefly Neuroscience, down from $397032.0 in the prior quarter.
  • Over the last five years, Treasury Shares for AIFF hit a ceiling of $1.7 million in Q3 2022 and a floor of $16668.0 in Q2 2025.
  • Median Treasury Shares over the past 5 years was $1.0 million (2021), compared with a mean of $894875.1.
  • Biggest five-year swings in Treasury Shares: changed 0.0% in 2020 and later increased 3.76% in 2022.
  • Firefly Neuroscience's Treasury Shares stood at $930211.0 in 2020, then changed by 0.0% to $930211.0 in 2021, then increased by 3.76% to $965211.0 in 2022, then changed by 0.0% to $965211.0 in 2023, then changed by 0.0% to $965211.0 in 2024.
  • The last three reported values for Treasury Shares were $965211.0 (Q2 2024), $965211.0 (Q1 2024), and $965211.0 (Q4 2023) per Business Quant data.